| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteremia | 32 | 2021 | 722 | 1.850 |
Why?
|
| Invasive Pulmonary Aspergillosis | 4 | 2020 | 49 | 1.070 |
Why?
|
| Cross Infection | 18 | 2014 | 548 | 0.950 |
Why?
|
| Antifungal Agents | 20 | 2024 | 877 | 0.920 |
Why?
|
| Catheterization, Central Venous | 12 | 2017 | 366 | 0.870 |
Why?
|
| Aspergillus | 8 | 2020 | 152 | 0.830 |
Why?
|
| Neoplasms | 53 | 2022 | 15928 | 0.740 |
Why?
|
| Hematologic Neoplasms | 13 | 2019 | 1950 | 0.700 |
Why?
|
| Blood | 7 | 2016 | 172 | 0.690 |
Why?
|
| Cytomegalovirus Infections | 15 | 2009 | 485 | 0.690 |
Why?
|
| Candidiasis | 10 | 2015 | 281 | 0.630 |
Why?
|
| Candidemia | 5 | 2017 | 61 | 0.610 |
Why?
|
| Candida glabrata | 6 | 2017 | 48 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 27 | 2021 | 3176 | 0.550 |
Why?
|
| Anti-Infective Agents, Local | 3 | 2012 | 112 | 0.540 |
Why?
|
| Fungemia | 8 | 2015 | 119 | 0.520 |
Why?
|
| Mycoses | 7 | 2016 | 396 | 0.510 |
Why?
|
| Gram-Negative Bacterial Infections | 7 | 2015 | 172 | 0.500 |
Why?
|
| BK Virus | 4 | 2020 | 126 | 0.500 |
Why?
|
| Immunocompromised Host | 15 | 2022 | 721 | 0.500 |
Why?
|
| Polyomavirus Infections | 4 | 2020 | 149 | 0.490 |
Why?
|
| Bacteriological Techniques | 5 | 2017 | 123 | 0.490 |
Why?
|
| Viral Matrix Proteins | 4 | 2015 | 182 | 0.480 |
Why?
|
| Microbial Sensitivity Tests | 20 | 2020 | 1073 | 0.480 |
Why?
|
| Tumor Virus Infections | 4 | 2020 | 249 | 0.480 |
Why?
|
| Opportunistic Infections | 8 | 2015 | 237 | 0.480 |
Why?
|
| Neutropenia | 13 | 2024 | 1001 | 0.460 |
Why?
|
| Drug Contamination | 2 | 2011 | 52 | 0.450 |
Why?
|
| Catheter-Related Infections | 7 | 2017 | 276 | 0.450 |
Why?
|
| Aspergillosis | 6 | 2017 | 249 | 0.440 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2012 | 51 | 0.420 |
Why?
|
| Gram-Positive Bacterial Infections | 6 | 2016 | 163 | 0.400 |
Why?
|
| Catheters, Indwelling | 5 | 2011 | 383 | 0.400 |
Why?
|
| Lung Diseases, Fungal | 4 | 2009 | 133 | 0.390 |
Why?
|
| Mucormycosis | 3 | 2022 | 118 | 0.370 |
Why?
|
| Pseudomonas Infections | 3 | 2001 | 166 | 0.360 |
Why?
|
| Mucorales | 2 | 2009 | 31 | 0.360 |
Why?
|
| Leukemia | 9 | 2024 | 1721 | 0.350 |
Why?
|
| Streptococcal Infections | 5 | 2014 | 312 | 0.350 |
Why?
|
| Platelet Transfusion | 1 | 2010 | 168 | 0.340 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 15 | 2020 | 6987 | 0.340 |
Why?
|
| Infection Control | 8 | 2011 | 276 | 0.340 |
Why?
|
| Gastrostomy | 1 | 2011 | 194 | 0.340 |
Why?
|
| Skin | 3 | 2012 | 1284 | 0.330 |
Why?
|
| Adult | 82 | 2024 | 81889 | 0.320 |
Why?
|
| Biofilms | 4 | 2016 | 203 | 0.320 |
Why?
|
| Enteral Nutrition | 1 | 2011 | 345 | 0.310 |
Why?
|
| Retrospective Studies | 53 | 2024 | 39800 | 0.310 |
Why?
|
| Middle Aged | 80 | 2019 | 90427 | 0.300 |
Why?
|
| Tertiary Healthcare | 2 | 2018 | 46 | 0.300 |
Why?
|
| Aspergillus fumigatus | 5 | 2018 | 138 | 0.300 |
Why?
|
| Pneumonia, Viral | 10 | 2012 | 709 | 0.300 |
Why?
|
| Humans | 144 | 2024 | 271941 | 0.290 |
Why?
|
| Zygomycosis | 1 | 2007 | 30 | 0.280 |
Why?
|
| Escherichia coli Infections | 3 | 2019 | 271 | 0.280 |
Why?
|
| Candida | 4 | 2015 | 171 | 0.280 |
Why?
|
| Antiviral Agents | 14 | 2013 | 1255 | 0.280 |
Why?
|
| Deglutition Disorders | 1 | 2011 | 488 | 0.280 |
Why?
|
| Respiratory Syncytial Virus Infections | 7 | 2013 | 431 | 0.270 |
Why?
|
| Male | 88 | 2019 | 128995 | 0.270 |
Why?
|
| Hyphae | 2 | 2009 | 44 | 0.270 |
Why?
|
| Blood Platelets | 2 | 2010 | 684 | 0.270 |
Why?
|
| Bone Marrow Transplantation | 13 | 2008 | 1772 | 0.260 |
Why?
|
| Virus Activation | 5 | 2016 | 236 | 0.260 |
Why?
|
| Aged | 62 | 2018 | 73494 | 0.250 |
Why?
|
| Respiratory Tract Infections | 4 | 2018 | 408 | 0.250 |
Why?
|
| Female | 86 | 2020 | 149187 | 0.250 |
Why?
|
| Daptomycin | 2 | 2016 | 39 | 0.250 |
Why?
|
| Echinocandins | 2 | 2017 | 134 | 0.240 |
Why?
|
| Fungi | 4 | 2024 | 148 | 0.240 |
Why?
|
| Moraxellaceae Infections | 1 | 2004 | 3 | 0.240 |
Why?
|
| Viridans Streptococci | 2 | 2014 | 17 | 0.240 |
Why?
|
| Cancer Care Facilities | 10 | 2016 | 908 | 0.240 |
Why?
|
| Fusariosis | 1 | 2024 | 11 | 0.230 |
Why?
|
| Azoles | 4 | 2024 | 48 | 0.230 |
Why?
|
| Ganciclovir | 6 | 2007 | 194 | 0.230 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2015 | 2474 | 0.230 |
Why?
|
| Staining and Labeling | 3 | 2018 | 466 | 0.230 |
Why?
|
| Vancomycin Resistance | 4 | 2006 | 60 | 0.220 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2018 | 269 | 0.210 |
Why?
|
| Fluconazole | 4 | 2017 | 109 | 0.210 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 349 | 0.210 |
Why?
|
| Drug Resistance, Fungal | 4 | 2017 | 92 | 0.210 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5690 | 0.210 |
Why?
|
| RNA, Viral | 3 | 2017 | 729 | 0.210 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2011 | 214 | 0.210 |
Why?
|
| Pseudomonas | 2 | 2001 | 23 | 0.210 |
Why?
|
| Adolescent | 39 | 2018 | 32687 | 0.200 |
Why?
|
| Legionellosis | 2 | 2015 | 17 | 0.200 |
Why?
|
| Young Adult | 22 | 2018 | 22127 | 0.200 |
Why?
|
| Mycobacterium avium Complex | 3 | 2005 | 33 | 0.200 |
Why?
|
| Salmonella Infections | 1 | 2021 | 43 | 0.190 |
Why?
|
| Disease Outbreaks | 5 | 2011 | 405 | 0.190 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 3 | 2012 | 88 | 0.190 |
Why?
|
| DNA, Ribosomal | 7 | 2015 | 105 | 0.190 |
Why?
|
| Virus Diseases | 3 | 2017 | 392 | 0.190 |
Why?
|
| Enterococcus faecium | 2 | 2016 | 48 | 0.190 |
Why?
|
| Stem Cell Transplantation | 4 | 2020 | 1423 | 0.190 |
Why?
|
| Cyclonic Storms | 1 | 2022 | 84 | 0.190 |
Why?
|
| Enterococcus | 4 | 2006 | 61 | 0.180 |
Why?
|
| Aged, 80 and over | 30 | 2016 | 31060 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2017 | 1534 | 0.180 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2000 | 251 | 0.180 |
Why?
|
| Carbapenems | 2 | 2019 | 63 | 0.180 |
Why?
|
| Drug Resistance, Bacterial | 5 | 2016 | 424 | 0.180 |
Why?
|
| Mycobacterium avium | 2 | 2005 | 21 | 0.180 |
Why?
|
| Vancomycin | 4 | 2016 | 292 | 0.180 |
Why?
|
| Simplexvirus | 2 | 2009 | 180 | 0.180 |
Why?
|
| Granuloma | 1 | 2001 | 159 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2010 | 812 | 0.170 |
Why?
|
| Cytomegalovirus | 6 | 2009 | 493 | 0.170 |
Why?
|
| Mycobacterium | 3 | 2012 | 60 | 0.160 |
Why?
|
| Cough | 2 | 2018 | 126 | 0.160 |
Why?
|
| Triazoles | 3 | 2024 | 629 | 0.160 |
Why?
|
| Amphotericin B | 3 | 2017 | 304 | 0.160 |
Why?
|
| RNA, Ribosomal, 16S | 6 | 2015 | 508 | 0.160 |
Why?
|
| Escherichia coli | 4 | 2019 | 1309 | 0.160 |
Why?
|
| Ribavirin | 5 | 2013 | 177 | 0.160 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2017 | 20 | 0.150 |
Why?
|
| DNA, Bacterial | 7 | 2014 | 604 | 0.150 |
Why?
|
| Cardiac Tamponade | 1 | 2018 | 51 | 0.150 |
Why?
|
| Nocardia Infections | 2 | 2011 | 36 | 0.150 |
Why?
|
| Polyenes | 1 | 2017 | 37 | 0.150 |
Why?
|
| Transplantation Conditioning | 4 | 2016 | 2359 | 0.150 |
Why?
|
| Cryptococcosis | 1 | 2018 | 70 | 0.150 |
Why?
|
| Mouth | 2 | 2011 | 125 | 0.150 |
Why?
|
| Pericarditis | 1 | 2018 | 62 | 0.150 |
Why?
|
| beta-Lactamases | 3 | 2019 | 223 | 0.140 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2022 | 1091 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 9 | 2015 | 2576 | 0.140 |
Why?
|
| Streptococcus | 2 | 2014 | 79 | 0.140 |
Why?
|
| beta-Lactam Resistance | 2 | 2014 | 53 | 0.140 |
Why?
|
| Decontamination | 1 | 2016 | 15 | 0.140 |
Why?
|
| Bacterial Infections | 3 | 2016 | 507 | 0.140 |
Why?
|
| Lung Diseases | 2 | 2001 | 755 | 0.140 |
Why?
|
| Urologic Diseases | 1 | 2016 | 84 | 0.130 |
Why?
|
| Candidiasis, Invasive | 2 | 2014 | 22 | 0.130 |
Why?
|
| Enterobacteriaceae | 1 | 2016 | 54 | 0.130 |
Why?
|
| Azabicyclo Compounds | 1 | 2016 | 40 | 0.130 |
Why?
|
| Mucor | 1 | 2015 | 18 | 0.130 |
Why?
|
| Larynx, Artificial | 1 | 2016 | 44 | 0.130 |
Why?
|
| Fluoroquinolones | 2 | 2014 | 131 | 0.130 |
Why?
|
| Equipment Contamination | 3 | 2004 | 86 | 0.130 |
Why?
|
| Incidence | 13 | 2024 | 5861 | 0.130 |
Why?
|
| Empyema, Pleural | 1 | 2016 | 48 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 74 | 0.130 |
Why?
|
| Genome, Fungal | 1 | 2015 | 56 | 0.130 |
Why?
|
| Ceftazidime | 1 | 2016 | 66 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 173 | 0.130 |
Why?
|
| Legionella | 1 | 2015 | 18 | 0.130 |
Why?
|
| Methylobacterium | 1 | 2015 | 1 | 0.130 |
Why?
|
| Candida albicans | 4 | 2011 | 188 | 0.130 |
Why?
|
| Viral Load | 1 | 2017 | 482 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2017 | 314 | 0.120 |
Why?
|
| Central Venous Catheters | 1 | 2016 | 100 | 0.120 |
Why?
|
| Polymorphism, Genetic | 3 | 2017 | 1559 | 0.120 |
Why?
|
| Herbaspirillum | 1 | 2014 | 6 | 0.120 |
Why?
|
| Texas | 14 | 2015 | 6435 | 0.120 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 1075 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 4 | 2007 | 3512 | 0.120 |
Why?
|
| Lung | 2 | 2009 | 3294 | 0.120 |
Why?
|
| Paramyxoviridae Infections | 3 | 2012 | 72 | 0.120 |
Why?
|
| Risk Factors | 19 | 2017 | 18047 | 0.120 |
Why?
|
| DNA Gyrase | 1 | 2014 | 26 | 0.120 |
Why?
|
| Culture Media | 5 | 2015 | 349 | 0.120 |
Why?
|
| Hematologic Diseases | 1 | 2016 | 255 | 0.120 |
Why?
|
| Graft vs Host Disease | 5 | 2016 | 2804 | 0.120 |
Why?
|
| Temperature | 2 | 2007 | 540 | 0.120 |
Why?
|
| Aerosols | 2 | 2013 | 149 | 0.120 |
Why?
|
| Scedosporium | 2 | 2004 | 24 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 792 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2018 | 669 | 0.110 |
Why?
|
| Lipopeptides | 1 | 2014 | 117 | 0.110 |
Why?
|
| Transplantation, Homologous | 10 | 2016 | 3036 | 0.110 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2018 | 461 | 0.110 |
Why?
|
| Stomatitis, Herpetic | 1 | 1993 | 6 | 0.110 |
Why?
|
| Cohort Studies | 9 | 2019 | 9494 | 0.110 |
Why?
|
| Autopsy | 4 | 2013 | 178 | 0.110 |
Why?
|
| Peptidomimetics | 1 | 2013 | 29 | 0.110 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 68 | 0.110 |
Why?
|
| Fusarium | 2 | 2003 | 57 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2017 | 2913 | 0.110 |
Why?
|
| Oxazolidinones | 1 | 2013 | 63 | 0.110 |
Why?
|
| Urinary Catheters | 1 | 2012 | 34 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 2016 | 533 | 0.100 |
Why?
|
| Adenoviridae Infections | 1 | 2013 | 114 | 0.100 |
Why?
|
| Rhodococcus equi | 1 | 2012 | 8 | 0.100 |
Why?
|
| 2-Propanol | 1 | 2012 | 8 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2015 | 493 | 0.100 |
Why?
|
| Acetamides | 1 | 2013 | 111 | 0.100 |
Why?
|
| Bacterial Load | 1 | 2012 | 45 | 0.100 |
Why?
|
| Influenza, Human | 4 | 2012 | 763 | 0.100 |
Why?
|
| Child | 23 | 2016 | 30499 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2012 | 64 | 0.100 |
Why?
|
| Staphylococcus epidermidis | 1 | 2012 | 66 | 0.100 |
Why?
|
| Drug Synergism | 2 | 2013 | 1364 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 335 | 0.100 |
Why?
|
| Yeasts | 1 | 2011 | 77 | 0.100 |
Why?
|
| Iodine | 1 | 2012 | 55 | 0.100 |
Why?
|
| Microbiological Techniques | 1 | 1991 | 41 | 0.100 |
Why?
|
| Serratia Infections | 1 | 2011 | 13 | 0.100 |
Why?
|
| Liposomes | 1 | 1993 | 710 | 0.100 |
Why?
|
| Serratia marcescens | 1 | 2011 | 20 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2013 | 900 | 0.090 |
Why?
|
| DNA, Fungal | 3 | 2007 | 148 | 0.090 |
Why?
|
| Mouthwashes | 1 | 2011 | 42 | 0.090 |
Why?
|
| Child, Preschool | 15 | 2016 | 17006 | 0.090 |
Why?
|
| Herpesvirus 4, Human | 1 | 2015 | 954 | 0.090 |
Why?
|
| Sensitivity and Specificity | 8 | 2018 | 5195 | 0.090 |
Why?
|
| Treatment Outcome | 17 | 2017 | 33874 | 0.090 |
Why?
|
| Anti-Infective Agents | 2 | 2013 | 465 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2009 | 1230 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2016 | 732 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 216 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2006 | 4998 | 0.090 |
Why?
|
| Rhizopus | 1 | 2009 | 39 | 0.080 |
Why?
|
| Colistin | 1 | 2009 | 37 | 0.080 |
Why?
|
| Intensive Care Units | 4 | 2014 | 743 | 0.080 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 2 | 2005 | 36 | 0.080 |
Why?
|
| Skin Diseases, Bacterial | 2 | 2002 | 42 | 0.080 |
Why?
|
| Academic Medical Centers | 3 | 2016 | 690 | 0.080 |
Why?
|
| Time Factors | 7 | 2017 | 13130 | 0.080 |
Why?
|
| Cluster Analysis | 4 | 2015 | 1074 | 0.080 |
Why?
|
| Parainfluenza Virus 2, Human | 1 | 2008 | 4 | 0.080 |
Why?
|
| Cystitis | 1 | 2010 | 109 | 0.080 |
Why?
|
| Hematologic Tests | 1 | 2009 | 85 | 0.080 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2010 | 194 | 0.080 |
Why?
|
| Epiglottitis | 1 | 2008 | 16 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2018 | 1544 | 0.080 |
Why?
|
| Gentian Violet | 1 | 2008 | 23 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 605 | 0.080 |
Why?
|
| Croup | 1 | 2008 | 16 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2014 | 940 | 0.080 |
Why?
|
| Antineoplastic Agents | 5 | 2010 | 14653 | 0.080 |
Why?
|
| Prevalence | 5 | 2017 | 3426 | 0.080 |
Why?
|
| Survival Analysis | 7 | 2017 | 9325 | 0.080 |
Why?
|
| Lymphocyte Depletion | 3 | 2007 | 311 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2007 | 1373 | 0.080 |
Why?
|
| Cause of Death | 2 | 2014 | 787 | 0.080 |
Why?
|
| Genes, Bacterial | 2 | 2014 | 271 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 2 | 2012 | 404 | 0.080 |
Why?
|
| Latex Fixation Tests | 1 | 2007 | 10 | 0.070 |
Why?
|
| Mycological Typing Techniques | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sinusitis | 2 | 2004 | 148 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2013 | 1514 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 229 | 0.070 |
Why?
|
| Anaerobiosis | 1 | 2007 | 21 | 0.070 |
Why?
|
| Mycology | 1 | 2007 | 8 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 2 | 2009 | 142 | 0.070 |
Why?
|
| Xanthomonadaceae | 1 | 2006 | 2 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2017 | 13402 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2015 | 2157 | 0.070 |
Why?
|
| Antibodies, Neoplasm | 1 | 2007 | 275 | 0.070 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 968 | 0.070 |
Why?
|
| Molecular Epidemiology | 2 | 2009 | 247 | 0.070 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2006 | 32 | 0.070 |
Why?
|
| Aspergillus niger | 2 | 2003 | 27 | 0.070 |
Why?
|
| Antigens, Viral | 3 | 2002 | 520 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 473 | 0.070 |
Why?
|
| Molecular Sequence Data | 5 | 2015 | 6782 | 0.070 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 97 | 0.060 |
Why?
|
| Drug Therapy, Combination | 5 | 2013 | 2366 | 0.060 |
Why?
|
| Campylobacter | 1 | 2005 | 29 | 0.060 |
Why?
|
| Campylobacter Infections | 1 | 2005 | 42 | 0.060 |
Why?
|
| Fungal Proteins | 2 | 2017 | 272 | 0.060 |
Why?
|
| Sterols | 1 | 2005 | 23 | 0.060 |
Why?
|
| DNA Primers | 3 | 2003 | 1513 | 0.060 |
Why?
|
| Liver Abscess | 1 | 2005 | 37 | 0.060 |
Why?
|
| Linezolid | 2 | 2016 | 70 | 0.060 |
Why?
|
| Risk Assessment | 6 | 2020 | 6883 | 0.060 |
Why?
|
| Rifampin | 3 | 2011 | 220 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 481 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2005 | 161 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 152 | 0.060 |
Why?
|
| Endocarditis | 1 | 2006 | 128 | 0.060 |
Why?
|
| Moraxella | 1 | 2004 | 16 | 0.060 |
Why?
|
| Dog Diseases | 1 | 2005 | 76 | 0.060 |
Why?
|
| Hepatitis C, Chronic | 1 | 2009 | 469 | 0.060 |
Why?
|
| Pneumonia, Bacterial | 2 | 2015 | 135 | 0.060 |
Why?
|
| Molecular Typing | 2 | 2014 | 56 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2015 | 7258 | 0.060 |
Why?
|
| Bronchitis | 1 | 2004 | 43 | 0.060 |
Why?
|
| Community-Acquired Infections | 2 | 2006 | 286 | 0.060 |
Why?
|
| Trichosporon | 1 | 2004 | 16 | 0.060 |
Why?
|
| Pichia | 1 | 2004 | 60 | 0.060 |
Why?
|
| Coccidioides | 1 | 2003 | 8 | 0.060 |
Why?
|
| Prototheca | 1 | 2003 | 2 | 0.060 |
Why?
|
| Gram-Negative Aerobic Bacteria | 1 | 2003 | 5 | 0.060 |
Why?
|
| Bacteria | 2 | 2013 | 652 | 0.060 |
Why?
|
| Fusobacterium Infections | 1 | 2003 | 30 | 0.060 |
Why?
|
| Aspergillus flavus | 1 | 2003 | 8 | 0.060 |
Why?
|
| Abscess | 1 | 2005 | 192 | 0.060 |
Why?
|
| Coccidioidomycosis | 1 | 2003 | 33 | 0.060 |
Why?
|
| Gordonia Bacterium | 1 | 2003 | 2 | 0.060 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2003 | 85 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 370 | 0.050 |
Why?
|
| Dogs | 1 | 2005 | 1169 | 0.050 |
Why?
|
| Transplantation, Autologous | 3 | 2007 | 2048 | 0.050 |
Why?
|
| Stomatitis | 1 | 2004 | 193 | 0.050 |
Why?
|
| Brain Abscess | 1 | 2003 | 69 | 0.050 |
Why?
|
| Ergosterol | 2 | 2017 | 9 | 0.050 |
Why?
|
| RNA, Bacterial | 1 | 2002 | 84 | 0.050 |
Why?
|
| Candida tropicalis | 1 | 2002 | 18 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2009 | 1237 | 0.050 |
Why?
|
| Mycobacterium scrofulaceum | 1 | 2002 | 2 | 0.050 |
Why?
|
| Pandemics | 1 | 2012 | 1606 | 0.050 |
Why?
|
| Genotype | 4 | 2014 | 4266 | 0.050 |
Why?
|
| Neutrophils | 2 | 2004 | 876 | 0.050 |
Why?
|
| Floods | 1 | 2022 | 16 | 0.050 |
Why?
|
| Device Removal | 1 | 2004 | 338 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2010 | 2446 | 0.050 |
Why?
|
| Voriconazole | 2 | 2017 | 115 | 0.050 |
Why?
|
| Salmonella | 1 | 2021 | 35 | 0.050 |
Why?
|
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2002 | 33 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 1982 | 168 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2002 | 67 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 3 | 2013 | 243 | 0.050 |
Why?
|
| Cholesterol | 1 | 2005 | 681 | 0.050 |
Why?
|
| Fingers | 1 | 2002 | 129 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2012 | 245 | 0.050 |
Why?
|
| Helicobacter pylori | 1 | 2010 | 1434 | 0.050 |
Why?
|
| Mycobacterium kansasii | 1 | 2000 | 9 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2010 | 1351 | 0.050 |
Why?
|
| Staphylococcal Infections | 3 | 2006 | 682 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2003 | 260 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2005 | 617 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1985 | 489 | 0.040 |
Why?
|
| Clostridium Infections | 2 | 2003 | 261 | 0.040 |
Why?
|
| Leukemia, Lymphoid | 1 | 2001 | 290 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2018 | 835 | 0.040 |
Why?
|
| Oxygen | 1 | 2005 | 800 | 0.040 |
Why?
|
| Lymphoma | 2 | 2006 | 1514 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2017 | 738 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2002 | 288 | 0.040 |
Why?
|
| Air Pollutants | 1 | 2002 | 135 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2016 | 636 | 0.040 |
Why?
|
| Software | 1 | 2007 | 1386 | 0.040 |
Why?
|
| Itraconazole | 3 | 2005 | 81 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2010 | 6489 | 0.040 |
Why?
|
| Multivariate Analysis | 5 | 2006 | 4352 | 0.040 |
Why?
|
| Animals | 6 | 2022 | 62823 | 0.040 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2006 | 1068 | 0.040 |
Why?
|
| Mannans | 2 | 2011 | 31 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2014 | 134 | 0.040 |
Why?
|
| Phylogeny | 2 | 2015 | 870 | 0.040 |
Why?
|
| Methenamine | 1 | 2018 | 9 | 0.040 |
Why?
|
| Bordetella bronchiseptica | 1 | 2018 | 5 | 0.040 |
Why?
|
| Bordetella Infections | 1 | 2018 | 4 | 0.040 |
Why?
|
| Rimantadine | 1 | 1998 | 5 | 0.040 |
Why?
|
| Amantadine | 1 | 1998 | 16 | 0.040 |
Why?
|
| Tuberculosis | 1 | 2005 | 614 | 0.040 |
Why?
|
| Infant | 6 | 2016 | 13936 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 4496 | 0.040 |
Why?
|
| Ciprofloxacin | 2 | 2015 | 90 | 0.040 |
Why?
|
| Transfusion Reaction | 1 | 1998 | 101 | 0.040 |
Why?
|
| DNA Fingerprinting | 2 | 2009 | 181 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 7476 | 0.040 |
Why?
|
| Spores, Fungal | 2 | 2009 | 35 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 337 | 0.040 |
Why?
|
| Alopecia Areata | 1 | 1998 | 58 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 1998 | 109 | 0.040 |
Why?
|
| Antimicrobial Stewardship | 1 | 2019 | 98 | 0.040 |
Why?
|
| Influenza A virus | 1 | 1998 | 166 | 0.040 |
Why?
|
| Herpesvirus 8, Human | 1 | 2017 | 108 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3651 | 0.030 |
Why?
|
| Coinfection | 1 | 2018 | 202 | 0.030 |
Why?
|
| Mycobacterium Infections | 1 | 1996 | 51 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 468 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 2001 | 187 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2017 | 212 | 0.030 |
Why?
|
| Blood Culture | 1 | 2016 | 32 | 0.030 |
Why?
|
| Onychomycosis | 1 | 2015 | 18 | 0.030 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2015 | 33 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 2001 | 994 | 0.030 |
Why?
|
| Pneumonia | 2 | 2017 | 798 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 485 | 0.030 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 2 | 2011 | 74 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 4138 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 203 | 0.030 |
Why?
|
| Piperacillin | 1 | 2015 | 30 | 0.030 |
Why?
|
| Penicillanic Acid | 1 | 2015 | 22 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 420 | 0.030 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2015 | 76 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2017 | 1061 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2014 | 12 | 0.030 |
Why?
|
| Betaproteobacteria | 1 | 2014 | 6 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 995 | 0.030 |
Why?
|
| Burkholderia cepacia | 1 | 2014 | 7 | 0.030 |
Why?
|
| Hodgkin Disease | 1 | 2003 | 1488 | 0.030 |
Why?
|
| Levofloxacin | 1 | 2015 | 56 | 0.030 |
Why?
|
| Infectious Disease Medicine | 1 | 2014 | 21 | 0.030 |
Why?
|
| Laryngectomy | 1 | 2016 | 243 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2015 | 189 | 0.030 |
Why?
|
| Staphylococcus aureus | 2 | 2011 | 563 | 0.030 |
Why?
|
| Myeloablative Agonists | 1 | 2016 | 386 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 14881 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 15269 | 0.030 |
Why?
|
| Cerulenin | 1 | 1993 | 1 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 244 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2017 | 1296 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2010 | 16242 | 0.030 |
Why?
|
| Minocycline | 2 | 2011 | 189 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 234 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 1996 | 210 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 303 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 16610 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 1248 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 1212 | 0.030 |
Why?
|
| Lipid Bilayers | 1 | 2013 | 57 | 0.030 |
Why?
|
| Pyuria | 1 | 2012 | 9 | 0.030 |
Why?
|
| Transplantation | 1 | 2013 | 56 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 1140 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 944 | 0.030 |
Why?
|
| Mice | 3 | 2022 | 36054 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 2841 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 178 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 606 | 0.030 |
Why?
|
| Drug Carriers | 1 | 1993 | 336 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2005 | 7791 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 1993 | 225 | 0.030 |
Why?
|
| Foscarnet | 2 | 1999 | 19 | 0.030 |
Why?
|
| Phospholipids | 1 | 2013 | 170 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 5105 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 299 | 0.030 |
Why?
|
| Recurrence | 3 | 2012 | 4887 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 312 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1995 | 583 | 0.020 |
Why?
|
| Species Specificity | 2 | 2003 | 810 | 0.020 |
Why?
|
| Tin Fluorides | 1 | 2011 | 3 | 0.020 |
Why?
|
| Calcium Phosphates | 1 | 2011 | 15 | 0.020 |
Why?
|
| beta-Lactams | 1 | 2011 | 63 | 0.020 |
Why?
|
| Blood-Borne Pathogens | 1 | 2011 | 12 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 6210 | 0.020 |
Why?
|
| Urine | 1 | 2011 | 142 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 464 | 0.020 |
Why?
|
| Solvents | 1 | 2011 | 68 | 0.020 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2011 | 41 | 0.020 |
Why?
|
| Syringes | 1 | 2011 | 40 | 0.020 |
Why?
|
| Disease Management | 1 | 2017 | 1111 | 0.020 |
Why?
|
| United States | 4 | 2011 | 16053 | 0.020 |
Why?
|
| Gels | 1 | 2011 | 113 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 8602 | 0.020 |
Why?
|
| Sodium Bicarbonate | 1 | 2011 | 58 | 0.020 |
Why?
|
| Disease Progression | 3 | 2012 | 6910 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 163 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2011 | 80 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 2669 | 0.020 |
Why?
|
| Streptococcus agalactiae | 1 | 2011 | 113 | 0.020 |
Why?
|
| Pyrimidines | 2 | 2018 | 3664 | 0.020 |
Why?
|
| Palivizumab | 1 | 2010 | 61 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 49 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2013 | 588 | 0.020 |
Why?
|
| Vacuoles | 1 | 2009 | 46 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2006 | 4399 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 2242 | 0.020 |
Why?
|
| Diagnostic Errors | 2 | 1991 | 531 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 245 | 0.020 |
Why?
|
| Ethanol | 1 | 2011 | 269 | 0.020 |
Why?
|
| Nasal Lavage Fluid | 1 | 2008 | 18 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 7827 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 1991 | 221 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2011 | 226 | 0.020 |
Why?
|
| Sterilization | 1 | 2008 | 13 | 0.020 |
Why?
|
| Hoarseness | 1 | 2008 | 26 | 0.020 |
Why?
|
| Heparin | 1 | 2011 | 346 | 0.020 |
Why?
|
| Acyclovir | 1 | 2009 | 80 | 0.020 |
Why?
|
| Baculoviridae | 1 | 2008 | 109 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2008 | 73 | 0.020 |
Why?
|
| Hospitalization | 3 | 2003 | 2202 | 0.020 |
Why?
|
| Legionnaires' Disease | 1 | 2008 | 13 | 0.020 |
Why?
|
| Interferons | 1 | 2009 | 301 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2012 | 342 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 1327 | 0.020 |
Why?
|
| Logistic Models | 2 | 2006 | 3469 | 0.020 |
Why?
|
| RNA, Ribosomal, 5.8S | 1 | 2007 | 8 | 0.020 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2007 | 14 | 0.020 |
Why?
|
| Acute Disease | 2 | 2000 | 2514 | 0.020 |
Why?
|
| Saliva | 1 | 2008 | 238 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 5804 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 593 | 0.020 |
Why?
|
| Galactose | 1 | 2007 | 79 | 0.020 |
Why?
|
| Alemtuzumab | 1 | 2007 | 208 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2009 | 719 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2010 | 3393 | 0.020 |
Why?
|
| Blood Component Removal | 1 | 2007 | 121 | 0.020 |
Why?
|
| Automation | 1 | 2007 | 154 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 1620 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12533 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 664 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 1143 | 0.020 |
Why?
|
| T-Lymphocytes | 3 | 2007 | 3947 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 4635 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2009 | 6236 | 0.020 |
Why?
|
| Medical Audit | 1 | 2007 | 198 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2006 | 5118 | 0.020 |
Why?
|
| Intracranial Embolism | 1 | 2006 | 40 | 0.020 |
Why?
|
| Gene Library | 1 | 2007 | 355 | 0.020 |
Why?
|
| APACHE | 1 | 2005 | 95 | 0.020 |
Why?
|
| Streptomycin | 1 | 1985 | 24 | 0.020 |
Why?
|
| Ethambutol | 1 | 1985 | 11 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 629 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2007 | 214 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1995 | 188 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2010 | 747 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2009 | 583 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1985 | 70 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 458 | 0.020 |
Why?
|
| Nasopharynx | 1 | 1995 | 117 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2006 | 153 | 0.020 |
Why?
|
| Isoniazid | 1 | 1985 | 72 | 0.020 |
Why?
|
| Pharynx | 1 | 1995 | 150 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 2470 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 257 | 0.010 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1995 | 172 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 291 | 0.010 |
Why?
|
| Life Tables | 1 | 1994 | 122 | 0.010 |
Why?
|
| Premedication | 1 | 1994 | 133 | 0.010 |
Why?
|
| Peptostreptococcus | 1 | 2003 | 7 | 0.010 |
Why?
|
| Bacteroides Infections | 1 | 2003 | 10 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2004 | 109 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3363 | 0.010 |
Why?
|
| Oncology Service, Hospital | 1 | 2004 | 49 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2007 | 751 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 1076 | 0.010 |
Why?
|
| Prognosis | 2 | 2016 | 22550 | 0.010 |
Why?
|
| Cell Wall | 1 | 2003 | 51 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 423 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1853 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 10365 | 0.010 |
Why?
|
| Actinomycetales Infections | 1 | 2003 | 18 | 0.010 |
Why?
|
| Tetramethylphenylenediamine | 1 | 1982 | 3 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10259 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2005 | 372 | 0.010 |
Why?
|
| Air Microbiology | 1 | 2002 | 24 | 0.010 |
Why?
|
| Water Microbiology | 1 | 2002 | 29 | 0.010 |
Why?
|
| Sepsis | 1 | 1988 | 689 | 0.010 |
Why?
|
| Feces | 1 | 2006 | 865 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1982 | 140 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2004 | 322 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3671 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 502 | 0.010 |
Why?
|
| Epidemiological Monitoring | 1 | 2002 | 83 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 343 | 0.010 |
Why?
|
| Hospital Design and Construction | 1 | 2002 | 13 | 0.010 |
Why?
|
| Critical Care | 1 | 2008 | 810 | 0.010 |
Why?
|
| Fatigue | 1 | 2008 | 1280 | 0.010 |
Why?
|
| Respiratory Protective Devices | 1 | 2002 | 15 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 609 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2002 | 104 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 730 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2002 | 220 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 887 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6270 | 0.010 |
Why?
|
| Length of Stay | 1 | 2009 | 2015 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 1429 | 0.010 |
Why?
|
| Sputum | 1 | 2001 | 158 | 0.010 |
Why?
|
| Seasons | 1 | 2002 | 337 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2001 | 150 | 0.010 |
Why?
|
| Contact Tracing | 1 | 2001 | 62 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1994 | 1432 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 2206 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 448 | 0.010 |
Why?
|
| Catheterization | 1 | 2003 | 425 | 0.010 |
Why?
|
| Lactams | 1 | 2000 | 27 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 2043 | 0.010 |
Why?
|
| Echocardiography | 1 | 2006 | 1241 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 1442 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 1214 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1402 | 0.010 |
Why?
|
| Filtration | 1 | 1998 | 88 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 1998 | 48 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1998 | 56 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1994 | 3540 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1998 | 184 | 0.010 |
Why?
|
| Protective Devices | 1 | 1997 | 20 | 0.010 |
Why?
|
| Patient Isolation | 1 | 1997 | 25 | 0.010 |
Why?
|
| Hand Disinfection | 1 | 1997 | 20 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1998 | 137 | 0.010 |
Why?
|
| Visitors to Patients | 1 | 1997 | 13 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 1304 | 0.010 |
Why?
|
| Inservice Training | 1 | 1997 | 74 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 5521 | 0.010 |
Why?
|
| Picornaviridae Infections | 1 | 1996 | 55 | 0.010 |
Why?
|
| Adenovirus Infections, Human | 1 | 1996 | 55 | 0.010 |
Why?
|
| Enterobacter | 1 | 1995 | 23 | 0.010 |
Why?
|
| Viremia | 1 | 1996 | 182 | 0.010 |
Why?
|
| Staphylococcus | 1 | 1995 | 98 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 846 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1998 | 433 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 13993 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1995 | 340 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 4891 | 0.010 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1996 | 215 | 0.010 |
Why?
|
| Risk | 1 | 1997 | 1950 | 0.010 |
Why?
|
| Coagulase | 1 | 1992 | 30 | 0.010 |
Why?
|
| Mitosporic Fungi | 1 | 1991 | 19 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1991 | 175 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1992 | 650 | 0.000 |
Why?
|
| Quality Control | 1 | 1988 | 467 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 7929 | 0.000 |
Why?
|
| Thrombosis | 1 | 1992 | 755 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1998 | 5755 | 0.000 |
Why?
|